Tomarce, Baby Boy .
HRN: 22-47-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/14/2023
01/21/2023
IVT
45mg
Q24
Neonatal Sepsis; Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes